News
If You Invested $25,000 in AbbVie In 2020, This Is How Much You Would Have Today
AbbVie (NYSE: ABBV) is a top healthcare company that's worth nearly $290 billion. It has a diverse business that generates revenue from many different therapeutic areas. Its bread and butter is the
Down 70%: 2 Growth Stocks Are Smart Buys in a Bear Market
Some investors may be skeptical of a bear market. Yet, savvy investors recognize this as an excellent investment opportunity. Despite having strong fundamentals, the majority of growth stocks have
You Can Boost Your Passive Income With These 3 Dividend Raises
Just in time for the dividend-stock lover on your holiday list, numerous companies have declared payout raises in recent days. All three are regular dividend payers, strong cash generators, and book
Here's What Could Happen to the Stock Market in 2023: The Good and the Bad
Investors all over are scratching their heads, trying to figure out where the market will head in 2023. Inflation has finally started to cool, but now the question is, how much of a hit will the
3 Numbers From the First Month of Netflix With Ads
Netflix (NASDAQ: NFLX) launched its ad-supported tier last month, and investors are eager to see how it fared.
After a report surfaced indicating the streaming service was falling short of
What This Dividend Stock Could Learn From Devon Energy
Oil and gas prices can be volatile. Because of that, energy companies have had a difficult time maintaining their dividend payments over the years. Many have had to cut their payouts during pricing
Is Google's YouTube Scoring a Touchdown With NFL Sunday Ticket?
The National Football League has found a new home for the NFL Sunday Ticket content package. After almost three decades as an exclusive offering on DirecTV, including six years of the satellite
The University of Colorado Lost $120 Million -- Don't Make Their Mistake
I've been writing for The Motley Fool since the '90s, and I have offered the following advice countless times: Don't keep money that you expect to need in the next five years (if not more years, to
This Is My Highest-Conviction Stock to Buy Before 2022 Ends
Picking market-beating stocks in a volatile economic environment is no easy feat, especially as some economists are calling for a deep recession next year. In an uncertain environment, though, it's
The Best Stocks to Invest $1,000 in Right Now
Investing in the stock market can be a great way to grow your wealth over the long term, but the past year has presented challenges for investors. Major indices, such as the S&P 500, posted
Will the Fed Start Cutting Interest Rates In 2023? It's Possible
The Federal Reserve went on a rampage this year, hiking its benchmark federal funds rate from practically zero to now inside a range of 4.25% and 4.5%, as the agency has moved quickly to try to get
What's Going On With Rivian Stock?
Rivian's (NASDAQ: RIVN) most recent conference call with analysts could provide clues about what's happening inside the company.
*Stock prices used were the afternoon prices of Dec. 20, 2022. The
Netflix's Ad Tier Is Struggling. Here's Why Its Stock Is Still a Buy.
If recent reports are to be believed, Netflix's (NASDAQ: NFLX) new ad-supported video-on-demand (AVOD) plan is not doing well. The streamer rolled out its $6.99 Basic with Ads tier on Nov. 3, 2022
Why Oceaneering International Stock Was Riding High This Week
Next-generation industrial technology company Oceaneering International (NYSE: OII) was riding the waves of investor affection this week. According to data compiled by S&P Global Market Intelligence
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Why ATN International Stock Was Leaping Higher This Week
Niche telecom company ATN International (NASDAQ: ATNI) attracted much interest this week. As a result, its share price was up by nearly 16% week to date as of Thursday evening, according to data
A New Bull Market Is Coming: 2 Growth Stocks Trading at 52-Week Lows to Buy Right Now
The benchmark S&P 500 stock market index is currently trading in bear territory with a year-to-date loss of 20%. Bear markets can be unnerving, and while it feels like things aren't improving in the
Down 49% in 2022, Is Amazon Stock a Buy for 2023?
Amazon (NASDAQ: AMZN) thrived at the pandemic's onset when hundreds of millions of consumers were shopping more online. That trend is reversing as economies have reopened. Amazon stock investors are
Better Buy: Microsoft Stock vs. Apple Stock
After a challenging year in 2022, stock market investors are interested in adding shares of excellent companies like Microsoft (NASDAQ: MSFT) and Apple (NASDAQ: AAPL) at lower prices.
*Stock prices
At a 52-Week Low, This Top-Notch Dividend Stock Is an Incredible Buying Opportunity
Units of Brookfield Infrastructure Partners (NYSE: BIP) have tumbled nearly 24% this year and recently hit a 52-week low at less than $31 a unit. That's a much steeper slide than shares of its
4 Green Flags for Lucid Group's Future
Lucid Group (NASDAQ: LCID) has disappointed lots of investors since it went public by merging with a special purpose acquisition company (SPAC) last July. The maker of luxury electric sedans
Turning 70 in 2023? Here's What You Need to Know.
Your 70th birthday is a big one, and one worth celebrating. But it's also an age that has significant implications in the context of retirement. If you'll be turning 70 in 2023, here's what you need
Will Regulators Shoot Down Broadcom's Acquisition of VMware?
In today's video, Jose Najarro and Nick Rossolillo discuss Broadcom (NASDAQ: AVGO), VMware (NYSE: VMW), why regulators may be pushing back on the acquisition, and what Broadcom investors might want
Tech Is in a Slump, but Broadcom Is Still Growing
In today's video, Jose Najarro and Nick Rossolillo discuss Broadcom (NASDAQ: AVGO), including an overview of the business and a closer look at its most recent earnings and future expectations. Check
Why Madrigal Pharmaceuticals Was a Top Stock This Week
This week was going down as one to remember for Madrigal Pharmaceuticals (NASDAQ: MDGL). According to data compiled by S&P Global Market Intelligence, the biotech's shares were an eye-watering 350%